Percutaneous Epidural Adhesiolysis (PEA) untuk Manajemen Nyeri Pinggang Bawah Kronis
Abstract
Latar Belakang dan Tujuan: Nyeri pinggang bawah yang disebabkan oleh penekanan radik saraf tulang belakang maupun thecal sac sering dijumpai dan dapat menimbulkan kecacatan. Percutaneous epidural adhesiolysis (PEA) adalah salah satu tindakan yang dilakukan untuk mengatasi nyeri sehingga penelitian ini bertujuan untuk mengevaluasi efektifitas PEA menggunakan lidokain 2% dalam mengatasi nyeri pinggang bawah.
Subyek dan Metode: Penelitian cohort retrospektif dengan lima data pasien diambil dari database bagian Bedah Saraf. Semua pasien dilakukan PEA dengan injeksi anestesi lokal menggunakan 5 mL lidokain 2%, pengukuran luaran menggunakan Visual Analog Score (VAS), Oswestry Disability Index (ODI) dan penggunaan obat opioid yang dianalisa pada bulan ke-3 dan 6 bulan setelah tindakan.
Hasil: Usia tertua adalah 60 tahun dengan 80% penderita adalah laki-laki dengan nilai maksimum VAS sebelum tindakan adalah 9, VAS 3 bulan pascatindakan adalah 3 sedangkan VAS 6 bulan pascatindakan adalah 2. Sehingga terdapat perbaikan VAS dan ODI yang signifikan (Friedman test dan post hoc Wilcoxon test) dengan nilai p<0,05. Satu pasien tetap menggunakan opioid hingga 6 bulan pascatindakan PEA.
Simpulan: Pengurangan nyeri yang signifikan disertai dengan perbaikan status fungsional terjadi pada pasien yang diberikan PEA dengan menggunakan anestetika lokal lidokain 2%.
Percutaneous Epidural Adhesiolysis (PEA) for Chronic Low Back Pain Management
Background and Objective: Chronic low back pain caused by compression of spinal nerves roots or thecal sac is common and can lead to disability. Percutaneous epidural adhesiolysis (PEA) is an interventional pain management to relieve the pain.This study aims to evaluate the effectiveness of the PEA using lidocaine 2% in relieving lower back pain.
Material and Methods: This retrospective cohort study was done using five patient’s data taken from medical record, with all patients had underwent PEA using 5 mL of 2% lidocaine, outcome measurements were evaluated using Visual Analogue Score (VAS), Oswestry Disability Index (ODI) and the useage of opioid drugs at 3rd and 6th month afterward.
Results: The oldest age was 60 years and 80% of patients were male with a maximum value of VAS before procedure was 9, VAS score at 3rd month was 3 and VAS score at 6th month was 2. The maximum value ODI before procedure was 90, ODI at 3rd month was 50, while the 6th month was 25. Friedman test and post hoc Wilcoxon test revealed a significant difference in VAS score between before procedure, 3rd month and 6th month post-procedure (p <0,05).
Conclusion: PEA with lidocaine 2%, is an effective treatment for chronic low back pain and can reduce pain thus increase fungsional state significantly.
Keywords
Full Text:
PDFReferences
Helm S, Benyamin RM, Chopra P, Deer TR, and Justiz R. Percutaneous adhesiolysis in the management of chronic low back pain in post lumbar surgery syndrome and spinal stenosis: a systematic review. Pain Physician 2012; 15:E435–E462.
Manchikanti L, Singh V, Cash KA, Pampati V. Assessment of effectiveness of percutaneous adhesiolysis and caudal epidural injections in managing post lumbar surgery syndrome: 2-year follow-up of a randomized controlled trial. Journal of Pain Research 2012;5:597–608.
Racz GB, Day MR, Heavner JE. Epidural lysis of adhesions and percutaneous neuroplasty. Pain Management – Current Issues and Opinions,www.intechopen.com.
Gerdesmeyer L, Wagenpfeil S, Birkenmaier C, Veihelmann A, Hauschild M, Wagner K, et al. Percutaneous epidural lysis of adhesions in chronic lumbar radicular pain: a randomized, double-blind placebo controlled trial. Pain Physician. 2013 May-Jun;16(3):185–96.
Manchikanti L, Cash KA, McManus CD, Pampati V. Assessment of effectiveness of percutaneous adhesiolysis in managing chronic low back pain secondary to lumbar central spinal canal stenosis. Int J Med Sci 2013; 10(1):50–59
Chun-jing H, Hao-xiong N, Jia-xiang N. The application of percutaneous lysis of epidural adhesions in patients with failed back surgery syndrome. Acta Cirúrgica Brasileira 2012; 27 (4):357.
Tomita S, Arphorn S, Muto T, Koetkhlai K, Naing SS, Chaikittiporn C. Prevalence and risk factors of low back pain among Thai and Myanmar migrant seafood processing factory workers in Samut Sakorn Province, Thailand. Industrial Health 2010;48:283–91.
Samad NIA, Abdullah H, Moin S, Tamrin SBM, Hashim Z. Prevalence of low back pain and its risk factors among school teachers. American Journal of Applied Sciences. 2010;7(5):634–39.
Manchikanti L, Rivera JJ, Pampati V, Damron KS, McManus CD, Brandon DE and Wilson SR. One day lumbar epidural adhesiolysis and hypertonic saline neurolysis in treatment of chronic low back pain: a randomized, double-blind trial. Pain Physician. 2004;7:177–86.
Oh CH, Ji GY, Goo Cho PG, Choi WS, Shin DA, Kim KN, Kang H. The catheter tip position and effects of percutaneous epidural neuroplasty in patients with lumbar disc disease during 6-months of follow-up. Pain Physician 2014;17:E599–E608.
Kim HJ, Rim BC, Lim JW, Park NK, Kang TW, Sohn MK, Beom J, Kang S. Efficacy of epidural neuroplasty versus transforaminal epidural steroid injection for the radiating pain caused by a herniated lumbar disc. Ann Rehabil Med 2013;37(6):824–31.
Jørgensen MB, Holtermann A, Gyntelberg F, Suadicani P. Physical fitness as a predictor of herniated lumbar disc disease – a 33-year follow-up in the Copenhagen male study. BMC Musculoskeletal Disorders 2013;14:86:2–6.
Cummins TR. Setting up for the block: the mechanism underlying lidocaine’s use-dependent inhibition of sodium channels. J Physiol. 2007;582.1:11.
Buck ML. Use of lidocaine for analgesia in children and adolescents. Pediatr Pharm. 2013;19(12):1–4.
DOI: https://doi.org/10.24244/jni.vol4i2.116
Refbacks
- There are currently no refbacks.
JNI is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License